Analytical Data
-
基因名
pagC
- Application
-
别名
pagC；Virulence membrane Protein PagC
-
种属
Erwinia
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
D2T690
-
表达区间
24-185aa
-
氨基酸序列
DSHALSIGYAQSRVQDFKNLRGVNLKYRYEPNSLLGVITSFSYMSAGGHEFDSLSWGDTYYDDRIKVKYYSLLIGPSYRINKYVSLYAVSGLGSSKLDLTQNYRHTNYTYTEHTASNTTSFAYGAGVQINPLKNIAIDISYEKSKINAKKINGFSMGIGYHF
-
分子量
25.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant E.coli bLg Protein，His
Cat：PA2000-537DB
Recombinant Human LEPRE1 Protein，GST
Cat：PA2000-8879
Protein Description
PagC is a virulence factor associated with the pathogenicity of Yersinia pestis, the bacterium responsible for the plague. This protein plays a key role in the bacterium's ability to evade the host's immune response, particularly by aiding in the formation of a protective capsule. The understanding of PagC is crucial for developing new therapeutic strategies against plague infections. Research on PagC has focused on its structure and function, revealing insights into how it interacts with host cells and contributes to the bacterium's survival in hostile environments. Additionally, studies have explored the recombinant expression of PagC to analyze its properties and potential applications in vaccine development. Investigating PagC through recombinant protein technologies allows researchers to create safer and more effective vaccines by utilizing non-pathogenic systems for antigen production. This line of research not only enhances our understanding of Yersinia pestis's virulence mechanisms but also contributes to broader efforts in infectious disease control and prevention. As antimicrobial resistance rises worldwide, elucidating the role of PagC in host-pathogen interactions represents a strategic focus in the development of novel therapeutic interventions.
